Glycyphagus domesticus allergen (Gly d)

Glycyphagus domesticus, commonly known as the grocer's itch mite, is a prevalent storage mite found in domestic dust and agricultural environments. The immune response to Glycyphagus domesticus allergens, such as the major allergen Gly d 2, involves a Type I hypersensitivity reaction mediated by allergen-specific IgE antibodies (Source: PubMed, PMID: 16433834). Upon exposure, these allergens cross-link IgE on the surface of mast cells and basophils, triggering the release of histamine and other inflammatory mediators. This physiological process leads to clinical manifestations including allergic rhinitis, asthma, and contact dermatitis, particularly in occupational settings like granaries or grocery stores (Source: NIH, StatPearls). Therapeutic management typically involves allergen avoidance, symptomatic relief with antihistamines or corticosteroids, and allergen-specific immunotherapy (AIT) to induce long-term immunological tolerance (Source: World Allergy Organization). AIT works by modulating the T-cell response and increasing the production of regulatory T cells and IgG4 antibodies (Source: Journal of Allergy and Clinical Immunology). Standardized allergen extracts are used in both diagnosis and treatment to ensure efficacy and safety (Source: WHO/IUIS Allergen Nomenclature). Understanding the molecular structure of these allergens is crucial for developing standardized diagnostic tools and effective desensitization protocols.

Other names

Grocer's itch mite allergensStorage mite allergensGly d 2Gly d 5Gly d 7Gly d 8Gly d 10Gly d 13

Allergen-specific immunotherapy (AIT) induces desensitization by shifting the immune response from a Th2-dominated profile to a Th1/Treg-mediated tolerance (Source: World Allergy Organization). Anti-IgE therapy (e.g., Omalizumab) binds to free IgE, preventing its interaction with the FcεRI receptor on mast cells and basophils (Source: PubChem). Antihistamines act as inverse agonists at the H1 histamine receptor (Source: StatPearls).